SCHEDULE: Hims & Hers CEO Boosts Stake to 10.3%

Andrew Dudum, CEO of Hims & Hers Health, Inc., has updated his beneficial ownership to 10.3% of the Class A common stock, reflecting a significant insider stake.

Summary

• Andrew Dudum, the Chief Executive Officer and a Board Director of Hims & Hers Health, Inc., beneficially owns an aggregate of 23,820,905 shares of the Issuer's Class A common stock.
• This ownership represents 10.3% of the outstanding Class A common stock, calculated based on 231,873,143 shares.
• The beneficial ownership includes 9,333,039 Class A shares held by affiliated trusts, 92,313 Class A shares held directly, and 8,377,623 Class V common shares held by affiliated trusts.
• Additionally, the ownership includes 164,368 Class A shares underlying restricted stock units expected to settle within 60 days.
• It also includes 5,643,186 Class A shares underlying stock options exercisable within 60 days.
• Further, 80,023 Class A shares underlying stock options are not exercisable within 60 days but vest through April 2027 (approximately 4,468 options per month).
• Another 130,353 Class A shares underlying stock options are not exercisable within 60 days but vest through March 2026 (approximately 21,725 options per month).
• The calculation excludes 1,296,568 Class A shares underlying restricted stock units not expected to settle within 60 days.
• All Class V Common Stock converts automatically into an equal number of Class A Common Stock upon transfer (with limited exceptions) or by Board resolution on or after the one-year anniversary of specific trigger conditions being met.

Sentiment

Score: 8

Explanation: The filing indicates a significant and continued beneficial ownership stake by the CEO, which is generally viewed positively as it aligns management's interests with shareholders and signals strong insider confidence in the company's long-term prospects.

Positives

• The CEO's substantial beneficial ownership of 10.3% of Class A common stock signals strong confidence in the company's future performance and aligns management interests with those of shareholders.
• A significant portion of the CEO's stake is held through trusts, suggesting a long-term investment horizon and commitment to the company's sustained growth.
• The diversified nature of the CEO's holdings, including Class A shares, Class V shares, restricted stock units, and stock options, indicates a comprehensive and vested interest in the company's equity performance.

Future Outlook

NA

Industry Context

NA

Corporate Governance

Legal Proceedings

• The Reporting Person (Andrew Dudum) has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last five years.
• The Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction that resulted in a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, or finding any violation with respect to such laws, during the last five years.

Stakeholder Impact

• Shareholders: The significant and continued beneficial ownership by the CEO (10.3%) suggests strong alignment of management's interests with those of public shareholders, potentially fostering greater investor confidence.
• Management/Employees: The CEO's substantial equity stake, including stock options and RSUs, reinforces his vested interest in the company's performance and long-term value creation.

Key Dates

Recommendation

The updated Schedule 13D reveals that Andrew Dudum, the CEO of Hims & Hers Health, Inc., maintains a substantial beneficial ownership of 10.3% of the Class A common stock. This significant insider stake, comprising a mix of direct holdings, trust-held shares, and various equity incentives (RSUs and options), demonstrates strong conviction and long-term alignment with shareholder interests. Such a high level of insider ownership is often viewed as a positive signal by seasoned investors, indicating management's confidence in the company's future prospects and commitment to driving shareholder value. This strong insider commitment makes the stock an attractive 'buy' for investors seeking companies with aligned leadership.

Keywords

Hims & Hers Health, Andrew Dudum, Beneficial Ownership, SEC Filing, Schedule 13D, Insider Ownership, Class A Common Stock, Class V Common Stock, Stock Options, Restricted Stock Units, Corporate Governance